(IN BRIEF) BioLabs | TUM is a new biotech incubator in Munich, created through a partnership between TUM Venture Labs, BioLabs, and Eli Lilly. Opening in early 2026 within an 1,800 m² refurbished building, the hub will host 15–20 early‑stage companies, providing fully equipped labs, … Read the full press release →
Posted in Business, Education, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged academic innovation, BioLabs, BioLabs | TUM, biotechnology hub, Catalyze360, coworking labs, deep‑tech ecosystem, early‐stage start‑ups, Eli Lilly and Company, global networks, lab infrastructure, mentorship, Mission BioCapital, Munich, partnership, R&D collaboration, therapeutic discovery, TUM Venture Labs, Unternehmertum